PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 15, 20240 citations

Supplementary Figure S3 from A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer

View Full Paper
TDTanya B. DorffLHLisa G. HorvathKAKaren A. Autio

Key Points

Key points are not available for this paper at this time.

Abstract

Duration of PSA response in dose expansion

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dorff et al. (2024) studied this question.

synapsesocial.com/papers/68e6f2aeb6db64358766d83chttps://doi.org/10.1158/1078-0432.25603408
Ask AI
Helpful
Bookmark
Share
View Full Paper